Suppr超能文献

药剂师使用动机性访谈和MOTIVE工具对疫苗接受度的影响。

The Impact of Motivational Interviewing and MOTIVE Tool Use by Pharmacists on Vaccine Acceptance.

作者信息

Chen Aleda M H, Anthony Alea, Balogun Adeola, Pereira Ruth, Cole Justin W

机构信息

School of Pharmacy, Cedarville University, 251 N. Main St., Cedarville, OH 45314, USA.

出版信息

Pharmacy (Basel). 2024 Jul 24;12(4):114. doi: 10.3390/pharmacy12040114.

Abstract

Vaccines have played a significant role in reducing infectious disease burden. However, vaccine hesitancy remains a persistent challenge in public health, including for pharmacists who often interact with patients regarding vaccines. Thus, this study assesses the impact of motivational interviewing (MI) training and the MI-based vaccine hesitancy discussion tools (MOTIVE) on pharmacists' management of vaccine hesitancy. Pharmacists in eight Midwestern pharmacy practices who completed MI and MOTIVE training and engaged with vaccine-hesitant patients participated in this study. The pharmacist participants completed post-encounter surveys identifying the vaccine discussed, the tool utilized, and the outcome of the conversation. Descriptive results from 362 encounters indicated that the primary reasons for hesitancy were safety (39%), care coordination (31.5%), and efficacy (30.4%). Post encounter, 35.4% of patients received vaccines, 26% planned to, 25.1% considered it, and 13.5% were uninterested. The findings highlight the importance of patient-centered communication, such as MI, between patients and pharmacists to identify and address reasons for vaccine hesitancy. Pharmacists, equipped with conversation tools such as the MOTIVE tools, may effectively influence vaccine acceptance. Future research should evaluate the utility of MI and the MOTIVE tools in other settings and regions.

摘要

疫苗在减轻传染病负担方面发挥了重要作用。然而,疫苗犹豫仍然是公共卫生领域持续存在的挑战,对于经常就疫苗问题与患者互动的药剂师来说也是如此。因此,本研究评估了动机性访谈(MI)培训以及基于MI的疫苗犹豫讨论工具(MOTIVE)对药剂师处理疫苗犹豫问题的影响。来自中西部八个药房的药剂师完成了MI和MOTIVE培训,并与对疫苗持犹豫态度的患者进行了接触,他们参与了本研究。药剂师参与者在每次接触后完成了调查,确定讨论的疫苗、使用的工具以及谈话的结果。362次接触的描述性结果表明,犹豫的主要原因是安全性(39%)、护理协调(31.5%)和有效性(30.4%)。接触后,35.4%的患者接种了疫苗,26%的患者计划接种,25.1%的患者考虑接种,13.5%的患者不感兴趣。研究结果强调了患者与药剂师之间以患者为中心的沟通(如MI)对于识别和解决疫苗犹豫原因的重要性。配备了诸如MOTIVE工具等沟通工具的药剂师可能会有效地影响疫苗接种率。未来的研究应评估MI和MOTIVE工具在其他环境和地区的效用。

相似文献

本文引用的文献

1
COVID-19 vaccine hesitancy: A Systematic review of cognitive determinants.新冠病毒疫苗犹豫:认知决定因素的系统评价
Health Promot Perspect. 2023 Apr 30;13(1):21-35. doi: 10.34172/hpp.2023.03. eCollection 2023.
4
Towards Ending Immunization Inequity.迈向消除免疫不平等。
Vaccines (Basel). 2021 Nov 24;9(12):1378. doi: 10.3390/vaccines9121378.
10
Beliefs around childhood vaccines in the United States: A systematic review.美国儿童疫苗接种相关信念:系统综述。
Vaccine. 2019 Oct 23;37(45):6793-6802. doi: 10.1016/j.vaccine.2019.08.068. Epub 2019 Sep 24.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验